191 related articles for article (PubMed ID: 17520685)
1. A rapid mass spectrometric strategy for the characterization of N- and O-glycan chains in the diagnosis of defects in glycan biosynthesis.
Faid V; Chirat F; Seta N; Foulquier F; Morelle W
Proteomics; 2007 Jun; 7(11):1800-13. PubMed ID: 17520685
[TBL] [Abstract][Full Text] [Related]
2. Conserved oligomeric Golgi complex subunit 1 deficiency reveals a previously uncharacterized congenital disorder of glycosylation type II.
Foulquier F; Vasile E; Schollen E; Callewaert N; Raemaekers T; Quelhas D; Jaeken J; Mills P; Winchester B; Krieger M; Annaert W; Matthijs G
Proc Natl Acad Sci U S A; 2006 Mar; 103(10):3764-9. PubMed ID: 16537452
[TBL] [Abstract][Full Text] [Related]
3. Improved and semi-automated reductive β-elimination workflow for higher throughput protein O-glycosylation analysis.
Kotsias M; Kozak RP; Gardner RA; Wuhrer M; Spencer DIR
PLoS One; 2019; 14(1):e0210759. PubMed ID: 30653606
[TBL] [Abstract][Full Text] [Related]
4. Rapid chemical de-N-glycosylation and derivatization for liquid chromatography of immunoglobulin N-linked glycans.
Kameyama A; Dissanayake SK; Thet Tin WW
PLoS One; 2018; 13(5):e0196800. PubMed ID: 29723274
[TBL] [Abstract][Full Text] [Related]
5. Rapid N-Glycan Profiling of Serum and Plasma by a Novel Slide-Based Imaging Mass Spectrometry Workflow.
Blaschke CRK; Black AP; Mehta AS; Angel PM; Drake RR
J Am Soc Mass Spectrom; 2020 Dec; 31(12):2511-2520. PubMed ID: 32809822
[TBL] [Abstract][Full Text] [Related]
6. Exploring the N-glycosylation pathway in Chlamydomonas reinhardtii unravels novel complex structures.
Mathieu-Rivet E; Scholz M; Arias C; Dardelle F; Schulze S; Le Mauff F; Teo G; Hochmal AK; Blanco-Rivero A; Loutelier-Bourhis C; Kiefer-Meyer MC; Fufezan C; Burel C; Lerouge P; Martinez F; Bardor M; Hippler M
Mol Cell Proteomics; 2013 Nov; 12(11):3160-83. PubMed ID: 23912651
[TBL] [Abstract][Full Text] [Related]
7. MALDI-TOF-MS characterization of N-linked glycoprotein derived from ginger with ACE inhibitory activity.
Zhao W; Chen Y; Xue S; Yu Z; Yu H; Liu J; Li J; Chen F
Food Funct; 2018 May; 9(5):2755-2761. PubMed ID: 29671439
[TBL] [Abstract][Full Text] [Related]
8. Congenital disorders of glycosylation with multiorgan disruption and immune dysregulation caused by compound heterozygous variants in MAN2B2.
Fan S; Wu H; Wang R; Chen Q; Zhang X
Mol Genet Genomic Med; 2024 Apr; 12(4):e2422. PubMed ID: 38622837
[TBL] [Abstract][Full Text] [Related]
9. Serum glycan signatures of gastric cancer.
Ozcan S; Barkauskas DA; Renee Ruhaak L; Torres J; Cooke CL; An HJ; Hua S; Williams CC; Dimapasoc LM; Han Kim J; Camorlinga-Ponce M; Rocke D; Lebrilla CB; Solnick JV
Cancer Prev Res (Phila); 2014 Feb; 7(2):226-35. PubMed ID: 24327722
[TBL] [Abstract][Full Text] [Related]
10. High-mannose glycans are elevated during breast cancer progression.
de Leoz ML; Young LJ; An HJ; Kronewitter SR; Kim J; Miyamoto S; Borowsky AD; Chew HK; Lebrilla CB
Mol Cell Proteomics; 2011 Jan; 10(1):M110.002717. PubMed ID: 21097542
[TBL] [Abstract][Full Text] [Related]
11. A mathematical model to derive N-glycan structures and cellular enzyme activities from mass spectrometric data.
Krambeck FJ; Bennun SV; Narang S; Choi S; Yarema KJ; Betenbaugh MJ
Glycobiology; 2009 Nov; 19(11):1163-75. PubMed ID: 19506293
[TBL] [Abstract][Full Text] [Related]
12. Applications and continued evolution of glycan imaging mass spectrometry.
McDowell CT; Lu X; Mehta AS; Angel PM; Drake RR
Mass Spectrom Rev; 2023 Mar; 42(2):674-705. PubMed ID: 34392557
[TBL] [Abstract][Full Text] [Related]
13. Analysis of Caenorhabditis Protein Glycosylation.
Paschinger K; Vanbeselaere J; Wilson IBH
Methods Mol Biol; 2024; 2762():123-138. PubMed ID: 38315363
[TBL] [Abstract][Full Text] [Related]
14. A Method for In-Depth Structural Annotation of Human Serum Glycans That Yields Biological Variations.
Song T; Aldredge D; Lebrilla CB
Anal Chem; 2015 Aug; 87(15):7754-62. PubMed ID: 26086522
[TBL] [Abstract][Full Text] [Related]
15. Glycan Imaging Mass Spectrometry: Progress in Developing Clinical Diagnostic Assays for Tissues, Biofluids, and Cells.
Blaschke CRK; McDowell CT; Black AP; Mehta AS; Angel PM; Drake RR
Clin Lab Med; 2021 Jun; 41(2):247-266. PubMed ID: 34020762
[TBL] [Abstract][Full Text] [Related]
16. Site-Specific Profiling of Serum Glycoproteins Using N-Linked Glycan and Glycosite Analysis Revealing Atypical N-Glycosylation Sites on Albumin and α-1B-Glycoprotein.
Sun S; Hu Y; Jia L; Eshghi ST; Liu Y; Shah P; Zhang H
Anal Chem; 2018 May; 90(10):6292-6299. PubMed ID: 29671580
[TBL] [Abstract][Full Text] [Related]
17. Simultaneous analyses of N-linked and O-linked glycans of ovarian cancer cells using solid-phase chemoenzymatic method.
Yang S; Höti N; Yang W; Liu Y; Chen L; Li S; Zhang H
Clin Proteomics; 2017; 14():3. PubMed ID: 28100988
[TBL] [Abstract][Full Text] [Related]
18. Modeling a congenital disorder of glycosylation type I in C. elegans: a genome-wide RNAi screen for N-glycosylation-dependent loci.
Struwe WB; Hughes BL; Osborn DW; Boudreau ED; Shaw KM; Warren CE
Glycobiology; 2009 Dec; 19(12):1554-62. PubMed ID: 19729382
[TBL] [Abstract][Full Text] [Related]
19. Development of a nanoLC LTQ orbitrap mass spectrometric method for profiling glycans derived from plasma from healthy, benign tumor control, and epithelial ovarian cancer patients.
Bereman MS; Williams TI; Muddiman DC
Anal Chem; 2009 Feb; 81(3):1130-6. PubMed ID: 19113831
[TBL] [Abstract][Full Text] [Related]
20. Rapid simulation of glycoprotein structures by grafting and steric exclusion of glycan conformer libraries.
Tsai YX; Chang NE; Reuter K; Chang HT; Yang TJ; von Bülow S; Sehrawat V; Zerrouki N; Tuffery M; Gecht M; Grothaus IL; Colombi Ciacchi L; Wang YS; Hsu MF; Khoo KH; Hummer G; Hsu SD; Hanus C; Sikora M
Cell; 2024 Feb; 187(5):1296-1311.e26. PubMed ID: 38428397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]